pharma news

News

Brainomix AI lends weight to Endeavor Bio's IPF trial data

An AI-based imaging tool from Brainomix has been used to enrich data from a phase 2a trial of Endeavor's idiopathic pulmonary fibrosis drug taladegib.

News

Pharvaris plans filings for HAE drug after pivotal trial win

Pharvaris has reported positive data from a phase 3 trial of its drug for preventing HAE attacks, setting up marketing applications next year.

News

Sandoz says it is entering "golden decade" in biosimilars

Sandoz said today it intends to double net sales between 2025 and 2035, fuelled by an acceleration in biosimilar medicine development.

News

It turns out COPD may be a laughing matter after all

Researchers in Türkiye have shown in a small clinical trial that laughter therapy can reduce breathing difficulties in COPD patients.

News

Novartis falls sharply on another major R&D setback

Novartis has suffered another pipeline blow, this time involving its highly anticipated neuromuscular disease therapy del-desiran.

News

Pharma body sees 'green shoots' in UK investment

The UK is starting to benefit from a "real partnership" between pharma and government, reversing years of diminishing investment, says the ABPI.

Brainomix AI lends weight to Endeavor Bio's IPF trial data

Pharvaris plans filings for HAE drug after pivotal trial win

Sandoz says it is entering "golden decade" in biosimilars

It turns out COPD may be a laughing matter after all

Novartis falls sharply on another major R&D setback

Pharma body sees 'green shoots' in UK investment

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks